Dupont Capital Management Corp Raises Stake in Danaher Co. (NYSE:DHR)

Dupont Capital Management Corp boosted its position in Danaher Co. (NYSE:DHRFree Report) by 13.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 56,210 shares of the conglomerate’s stock after buying an additional 6,725 shares during the period. Danaher makes up approximately 1.1% of Dupont Capital Management Corp’s investment portfolio, making the stock its 27th largest holding. Dupont Capital Management Corp’s holdings in Danaher were worth $13,004,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. FAS Wealth Partners Inc. boosted its position in Danaher by 33.5% in the fourth quarter. FAS Wealth Partners Inc. now owns 6,868 shares of the conglomerate’s stock valued at $1,589,000 after buying an additional 1,722 shares during the last quarter. Drive Wealth Management LLC boosted its position in Danaher by 3.1% in the 4th quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate’s stock worth $344,000 after purchasing an additional 44 shares in the last quarter. First Citizens Bank & Trust Co. boosted its position in Danaher by 0.6% in the 4th quarter. First Citizens Bank & Trust Co. now owns 26,611 shares of the conglomerate’s stock worth $6,156,000 after purchasing an additional 149 shares in the last quarter. SNS Financial Group LLC purchased a new stake in Danaher in the 4th quarter worth approximately $216,000. Finally, Sigma Investment Counselors Inc. boosted its position in Danaher by 5.5% in the 4th quarter. Sigma Investment Counselors Inc. now owns 28,506 shares of the conglomerate’s stock worth $6,594,000 after purchasing an additional 1,492 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other news, Director Teri List sold 3,289 shares of the stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total transaction of $816,724.48. Following the completion of the transaction, the director now directly owns 19,726 shares in the company, valued at approximately $4,898,360.32. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, Director Teri List sold 3,289 shares of the stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total transaction of $816,724.48. Following the completion of the transaction, the director now directly owns 19,726 shares in the company, valued at approximately $4,898,360.32. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Georgeann Couchara sold 2,622 shares of the stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $242.67, for a total value of $636,280.74. Following the transaction, the senior vice president now owns 4,244 shares of the company’s stock, valued at $1,029,891.48. The disclosure for this sale can be found here. Insiders sold 32,957 shares of company stock valued at $8,265,802 in the last three months. 11.10% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

DHR has been the topic of several recent research reports. Citigroup upped their price objective on Danaher from $255.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Barclays downgraded Danaher from an “overweight” rating to an “equal weight” rating and set a $240.00 target price for the company. in a research note on Wednesday, January 24th. TheStreet raised Danaher from a “c+” rating to a “b-” rating in a research note on Friday, December 8th. Raymond James upped their target price on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Finally, Royal Bank of Canada upped their target price on Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 31st. Seven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $266.00.

Read Our Latest Research Report on DHR

Danaher Stock Down 0.7 %

Shares of DHR opened at $245.98 on Wednesday. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $259.00. The company has a market capitalization of $182.16 billion, a PE ratio of 38.49, a price-to-earnings-growth ratio of 3.77 and a beta of 0.83. The stock has a fifty day simple moving average of $248.33 and a two-hundred day simple moving average of $230.34. The company has a quick ratio of 1.37, a current ratio of 1.68 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.91 by $0.18. Danaher had a return on equity of 12.25% and a net margin of 17.26%. The business had revenue of $6.41 billion during the quarter, compared to the consensus estimate of $6.10 billion. During the same period last year, the company earned $2.87 EPS. The company’s revenue for the quarter was down 10.2% on a year-over-year basis. As a group, equities analysts forecast that Danaher Co. will post 7.62 EPS for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Thursday, March 28th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Wednesday, March 27th. This is an increase from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s dividend payout ratio (DPR) is 16.90%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.